Brief: Resonance Health Says Is Contracted To Provide Liver-Iron-Concentration Quantification Services
27/01/2022 04:35
Jan 27 (Reuters) - Resonance Health Ltd RHT.AX :
* CONTRACTED TO PROVIDE LIVER-IRON-CONCENTRATION
QUANTIFICATION
SERVICES FOR HANGZHOU ZEDE PHARMA-TECH CO
* FERRISCAN TO BE USED BY HANGZHOU ZEDE PHARMA-TECH CO. IN
ITS
PHASE IIB CLINICAL STUDY
Source text for Eikon: ID:nASX4SSRh0
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co